Search research articles
Contact Us
Filters
Showing results (1651-1660 of 1,779) with videos related to
Page
of 178
Sort By:
Mabs
|
May 15, 2023
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
Ana Antunes, Luis Alvarez-Vallina, Federico Bertoglio, et al.
Mabs
|
May 16, 2023
High concentration formulation developability approaches and considerations
Jonathan Zarzar, Tarik Khan, Maniraj Bhagawati, et al.
Mabs
|
May 30, 2014
Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts
Sonia Chamorro, Maria Vela, Ana Franco-Villanueva, et al.
Mabs
|
August 4, 2020
A general evidence-based sequence variant control limit for recombinant therapeutic protein development
Aming Zhang, Zhengwei Chen, Meinuo Li, et al.
Mabs
|
August 4, 2020
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies
Mitchell Evers, Toine Ten Broeke, J H Marco Jansen, et al.
Mabs
|
August 4, 2020
Conjugation of a peptide to an antibody engineered with free cysteines dramatically improves half-life and activity
Raul C Camacho, Seohee You, Katharine E D'Aquino, et al.
Mabs
|
March 20, 2015
An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies
Patricia Estep, Isabelle Caffry, Yao Yu, et al.
Mabs
|
July 10, 2020
A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors
Michael W Bishop, Paul R Hutson, Jacquelyn A Hank, et al.
Mabs
|
May 17, 2014
Generation of a high-fidelity antibody against nerve growth factor using library scanning mutagenesis and validation with structures of the initial and optimized Fab-antigen complexes
Sherry L La Porte, Charles Eigenbrot, Mark Ultsch, et al.
Mabs
|
May 20, 2014
Insights into HER2 signaling from step-by-step optimization of anti-HER2 antibodies
Wenyan Fu, Yuxiao Wang, Yunshan Zhang, et al.
Page
of 178
Search research articles
Search
Showing results (1651-1660 of 1,779) with videos related to
Sort By:
Page
of 178
Mabs
|
May 15, 2023
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
Ana Antunes, Luis Alvarez-Vallina, Federico Bertoglio, et al.
Mabs
|
May 16, 2023
High concentration formulation developability approaches and considerations
Jonathan Zarzar, Tarik Khan, Maniraj Bhagawati, et al.
Mabs
|
May 30, 2014
Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts
Sonia Chamorro, Maria Vela, Ana Franco-Villanueva, et al.
Mabs
|
August 4, 2020
A general evidence-based sequence variant control limit for recombinant therapeutic protein development
Aming Zhang, Zhengwei Chen, Meinuo Li, et al.
Mabs
|
August 4, 2020
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies
Mitchell Evers, Toine Ten Broeke, J H Marco Jansen, et al.
Mabs
|
August 4, 2020
Conjugation of a peptide to an antibody engineered with free cysteines dramatically improves half-life and activity
Raul C Camacho, Seohee You, Katharine E D'Aquino, et al.
Mabs
|
March 20, 2015
An alternative assay to hydrophobic interaction chromatography for high-throughput characterization of monoclonal antibodies
Patricia Estep, Isabelle Caffry, Yao Yu, et al.
Mabs
|
July 10, 2020
A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors
Michael W Bishop, Paul R Hutson, Jacquelyn A Hank, et al.
Mabs
|
May 17, 2014
Generation of a high-fidelity antibody against nerve growth factor using library scanning mutagenesis and validation with structures of the initial and optimized Fab-antigen complexes
Sherry L La Porte, Charles Eigenbrot, Mark Ultsch, et al.
Mabs
|
May 20, 2014
Insights into HER2 signaling from step-by-step optimization of anti-HER2 antibodies
Wenyan Fu, Yuxiao Wang, Yunshan Zhang, et al.
Page
of 178